MANGAN MICHAEL D 4
4 · MCCORMICK & CO INC · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
McCormick (MKC) Director Michael Mangan Exercises Options, Sells Shares
What Happened
- Michael D. Mangan, a director of McCormick & Co. (MKC), exercised options and conducted a related sale on Feb 9, 2026. The filing shows he exercised option-related rights covering shares and ended up acquiring 5,000 shares (recorded at $49.96 each, total $249,800) and disposed of 5,000 shares in an open-market sale at $67.92 each for $339,600. A separate derivative line shows 5,000 shares disposed at $0, which reflects option/derivative settlement as part of the exercise process.
- This is effectively a cashless-style exercise combined with a sale: options were exercised and some resulting shares were sold to cover costs/taxes while 5,000 shares were retained. The sale is a routine disposition; the exercise is not a market-directional purchase.
Key Details
- Transaction date: 2026-02-09 (reported on Form 4 filed 2026-02-10 — filed promptly)
- Open-market sale: 5,000 shares @ $67.92 = $339,600
- Exercise/Acquisition: 5,000 shares @ $49.96 = $249,800
- Derivative disposition: 5,000 shares @ $0 (reflects option settlement/surrender)
- Footnote: F1 — Options exercised; no purchase price required.
- Shares owned after transaction: Not specified in the provided summary (not reported here).
Context
- For retail investors: this looks like a typical options exercise paired with a sell-to-cover or cashless exercise — the insider exercised option rights and sold a portion of the resulting shares while retaining others. Such transactions are common and do not by themselves indicate a change in company outlook.
Insider Transaction Report
Form 4
MANGAN MICHAEL D
Director
Transactions
- Exercise/Conversion
Common Stock - Voting
2026-02-09$49.96/sh+5,000$249,800→ 48,029 total - Sale
Common Stock - Voting
2026-02-09$67.92/sh−5,000$339,600→ 43,029 total - Exercise/Conversion
Options - Right to Buy
[F1]2026-02-09−5,000→ 0 totalExercise: $49.96From: 2017-03-30Exp: 2026-03-29→ Common Stock - Voting (5,000 underlying)
Holdings
- 4,234
Common Stock - Non Voting
Footnotes (1)
- [F1]Options exercised; no purchase price required.
Signature
Jason E. Wynn, Attorney-in-Fact|2026-02-10